Pharmacokinetics, Safety, Efficacy and Acceptability of Daclatasvir Plus Sofosbuvir in HCV-infected Children

NCT05854511 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

HCV

Interventions

DRUG: Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets

Sponsor

Ain Shams University

Collaborators

[object Object]